Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo
Thomas Dirschka(Witten/Herdecke University), H Mensing(Dermatologikum Hamburg), M. Foguet(Biofrontera (Germany)), Karin Wernicke‐Panten, F. Borrosch(University of Vechta), Beate Schmitz(Biofrontera (Germany)), Dirk H. Gröne, Christoph Helwig(Merck KGaA, Darmstadt (Germany)), Martin Deichmann(Gollwitzer-Meier-Klinik), Winfried Klövekorn, Uwe Reinhold, Carola Berking(Universitätsklinikum Erlangen), R. Dominicus, Hermann Lübbert(Biofrontera (Germany)), Peter Radny(Dermatopathologie Friedrichshafen), Günther F.L. Hofbauer(University of Zurich), F. Hübinger(University of Wuppertal), Peter Wolf(University Hospital Heidelberg), M. Tanner, Lars Jenne, Herbert Hönigsmann, Marion Moers-Carpi, Rolf‐Markus Szeimies(Knappschaftskrankenhaus Recklinghausen), Maria S. Simon(LMU Klinikum), Claus Oster‐Schmidt(DRK Krankenhaus Altenkirchen-Hachenburg), G. Krähn‐Senftleben, P. Lehmann, Linda Karl, H. Brüning, Kristian Reich(Dermatologikum Hamburg), Michael Sebastian(Mahlo (Germany))
Cited by 181
Related Papers
Non-melanoma skin cancer
|The Lancet|2010|874
Oxygen in acute and chronic wound healing
|British Journal of Dermatology|2010|789
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus
|Journal of the American Academy of Dermatology|2006|654
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Skin ageing
|Journal of the European Academy of Dermatology and Venereology|2011|423